In this episode, we take a deep dive into the global epidemic of fatty liver disease, also known as metabolic dysfunction associated steatotic liver disease (MASLD). Dr. Noureddin sheds light on alarming statistics: nearly one in four adults globally suffers from this condition, which can lead to serious liver complications. We discuss how fatty liver disease often accompanies other metabolic disorders, such as type 2 diabetes, hypertension, and elevated cholesterol levels, creating a complex web of health challenges for affected individuals.
The conversation touches upon the epidemiology of fatty liver disease, exploring how socioeconomic factors and lifestyle choices contribute to its rapid proliferation. Dr. Noureddin explains the disease's natural history, detailing how it can progress from simple steatosis to non-alcoholic steatohepatitis (NASH), cirrhosis, and even liver cancer. We discuss the critical importance of early diagnosis and risk assessment, as many individuals remain asymptomatic until the disease reaches advanced stages.
Furthermore, our discussion highlights the increasing need for liver transplants due to the progression of fatty liver disease complications. Dr. Noureddin shares breakthroughs in research and potential new therapies on the horizon, including pharmacologic treatments aimed at reversing liver damage and improving metabolic health.
For those seeking to learn more or get involved in the discussion about fatty liver disease, feel free to reach out to me at DrJoeGalati.com.
#FattyLiverDisease
#MetabolicHealth
#LiverResearch
#Diabetes
#Obesity
Join us for this crucial conversation as we aim to raise awareness and provide insights into the complexities of fatty liver disease and its growing impact on global health!
Hosted on Acast. See acast.com/privacy for more information.